Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions
Francesca Battaglin, Madiha Naseem, Alberto Puccini, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer
Wei Xu, Gai Zhou, Huizhi Wang, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 10, pp. 2901-2912
Open Access | Times Cited: 155
Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
Chang Zeng, Emily K. Stroup, Zhou Zhang, et al.
Cancer Communications (2019) Vol. 39, Iss. 1, pp. 1-9
Open Access | Times Cited: 77
Down-regulation of lncRNA XIST inhibits cell proliferation via regulating miR-744/RING1 axis in non-small cell lung cancer
Wang Jing-lu, Haibo Cai, Zhaoxia Dai, et al.
Clinical Science (2019) Vol. 133, Iss. 14, pp. 1567-1579
Closed Access | Times Cited: 46
Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
Alberto Puccini, Francesca Battaglin, Maria Laura Iaia, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000404-e000404
Open Access | Times Cited: 41
MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis
Zhengmao Lu, Tianhang Luo, Tao Pang, et al.
Open Biology (2019) Vol. 9, Iss. 9
Open Access | Times Cited: 41
High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients
Laura Necula, Lilia Matei, Denisa Dragu, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 22, pp. 3024-3033
Open Access | Times Cited: 29
Clinical utility and applicability of circulating tumor DNA testing in esophageal cancer: a systematic review and meta-analysis
Swathikan Chidambaram, Sheraz R. Markar
Diseases of the Esophagus (2021) Vol. 35, Iss. 2
Open Access | Times Cited: 26
Multivariate Cox regression analysis of prognostic genes and therapeutic mechanisms of gastric cancer
Yangyang Xiao, Zhiru Zhong, Chunli Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Integrative bioinformatics analysis of high-throughput sequencing and in vitro functional analysis leads to uncovering key hub genes in esophageal squamous cell carcinoma
Feng Shen, Xing Liu, Fengjiao Ding, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access
Twenty-five years of WWOX insight in cancer: a treasure trove of knowledge
Raneem Y. Hammouz, Izabela Baryła, Ewa Styczeń-Binkowska, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Open Access
WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells
Damin Chai, Yanzi Qin, Shiwu Wu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 27
<p>Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma</p>
Nan Zhang, Junping Shi, Xiaoliang Shi, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12797-12809
Open Access | Times Cited: 26
A novel positive feedback loop of linc02042 and c-Myc mediated by YBX1 promotes tumorigenesis and metastasis in esophageal squamous cell carcinoma
Jiahui Du, Guangzhao Zhang, Hongli Qiu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
Ana Moreira, Rui M. Ferreira, Patrı́cia Carneiro, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 15
Long noncoding RNA PXN-AS1-L promotes non-small cell lung cancer progression via regulating PXN
Zhifa Zhang, Zhaohui Peng, Junying Cao, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy
Swathikan Chidambaram, Viknesh Sounderajah, Nick Maynard, et al.
Annals of Surgical Oncology (2021) Vol. 29, Iss. 3, pp. 1977-1990
Open Access | Times Cited: 19
Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities
Ryan J. King, Fang Qiu, Fang Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Effects of Helicobacter pylori on the expression of the FTO gene and its biological role in gastric cancer
Shuqin Gui, Qinrong Wang, Liya Bao, et al.
Oncology Letters (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 7
<p>Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis</p>
Xi Yang, Qunxiong Zhang, Bugao Guan
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 11445-11457
Open Access | Times Cited: 18
Genetically engineered mouse models of esophageal cancer
Reihaneh Alsadat Mahmoudian, Moein Farshchian, Mohammad Reza Abbaszadegan
Experimental Cell Research (2021) Vol. 406, Iss. 2, pp. 112757-112757
Closed Access | Times Cited: 14
Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer
Mingtang Zeng, Chao Pi, Ke Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Viruses and esophageal cancer
Carolyn Chang, Stephanie G. Worrell
Diseases of the Esophagus (2020) Vol. 33, Iss. 12
Open Access | Times Cited: 13
NF-Y subunits overexpression in gastric adenocarcinomas (STAD)
Alberto Gallo, Mirko Ronzio, Eugenia Bezzecchi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Real-World Association of HER2/ ERBB2 Concordance with Trastuzumab Clinical Benefit in Advanced Esophagogastric Cancer
Stacey Stein, Jeremy Snider, Siraj M. Ali, et al.
Future Oncology (2021) Vol. 17, Iss. 31, pp. 4101-4114
Open Access | Times Cited: 11
HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 1, pp. 10-10
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top